NYSE Euronext (NYX) today announced trading volumes for its
global derivatives and cash equities exchanges for December 20121.
Global derivatives average daily volume (“ADV”) of 7.5 million
contracts in December 2012 was down slightly compared to December
2011 and decreased 8.0% from November 2012 levels on seasonally
slower trading activity. European derivatives fixed income ADV,
however, increased 17.4% from December 2011 levels. Trading volumes
in European and U.S. equities, declined both year-over-year and
month-over-month.
Highlights
- NYSE Euronext global derivatives ADV in
December 2012 of 7.5 million contracts decreased 0.2% compared to
December 2011, and decreased 8.0% from November 2012 levels.
- NYSE Euronext European derivatives
products ADV in December 2012 of 3.5 million contracts increased
1.5% compared to December 2011, but decreased 12.4% from November
2012 levels. Excluding Bclear, NYSE Liffe's trade administration
and clearing service for OTC products, European derivatives
products ADV increased 8.5% compared to December 2011 and increased
1.5% from November 2012.
- NYSE Euronext U.S. equity options (NYSE
Arca and NYSE Amex Options) ADV of 3.9 million contracts in
December 2012 decreased 1.2% compared to December 2011 levels, and
decreased by 4.4% from November 2012 levels. NYSE Euronext’s U.S.
options exchanges accounted for 27.2% of total U.S. consolidated
equity options trading in December 2012, down from 27.7% in
December 2011 and down from 28.1% in November 2012.
- NYSE Liffe U.S. ADV of approximately
72,600 contracts decreased from 89,600 contracts in December 2011,
but increased from 51,500 contracts in November 2012.
- NYSE Euronext European cash products
ADV of 1.1 million transactions in December 2012 decreased 20.2%
compared to December 2011 and decreased 8.7% compared to November
2012.
- NYSE Euronext U.S. cash products (NYSE,
NYSE Arca and NYSE-MKT) handled ADV of 1.5 billion shares in
December 2012 decreased 14.7% compared to December 2011 and
decreased 3.4% compared to November 2012. NYSE Euronext’s Tape A
matched market share in December 2012 was 31.9%, down from 33.4% in
December 2011, but up from 31.7% in November 2012.
- The preliminary average net revenue per
transaction type (as defined below) for each of the primary trading
venues in the fourth quarter of 2012 is included below:
Preliminary Trading Venue
4Q11 3Q12 4Q12
European Derivatives (ex. Bclear)1 $0.698
$0.657 $0.67 U.S. Derivatives2
$0.148 $0.144 $0.14 European
Cash3 $0.582 $0.537 $0.58 U.S.
Cash4 $0.039
$0.040 $0.040 1 Average net
revenue per contract, excluding Bclear. 2 Average net revenue per
contract. Excludes NYSE Liffe U.S. trading volume. 3 Average net
revenue per transaction. 4 Average net revenue per 100 shares
handled.
Derivatives Trading
European Derivatives
- NYSE Euronext European derivatives
products ADV in December 2012 was 3.5 million futures and options
contracts, an increase of 1.5% from December 2011, but a decrease
of 12.4% from November 2012.
- The 3.5 million in European derivatives
futures and options contracts ADV in December 2012 consisted of 2.4
million contracts executed through our full-service LIFFE CONNECT
trading platform and 1.1 million contracts, or 31.6%, executed
through Bclear, NYSE Liffe's trade administration and clearing
service for OTC products. Excluding Bclear, European derivatives
products ADV increased 8.5% compared to December 2011 and increased
1.5% from November 2012.
- In the fourth quarter of 2012, European
derivatives products ADV of 3.5 million contracts was 2.3% below
prior year levels. The 3.5 million in futures and options contracts
ADV in the fourth quarter of 2012 consisted of 2.3 million
contracts executed through LIFFE CONNECT trading platform and 1.2
million contracts, or 33.7%, executed through Bclear.
- For the full-year 2012, European
derivatives products ADV of 3.7 million contracts was 16.8% below
prior year levels. The 3.7 million in futures and options contracts
ADV year-to-date consisted of 2.6 million contracts executed
through LIFFE CONNECT trading platform and 1.1 million contracts,
or 29.7%, executed through Bclear.
- Total fixed income products ADV of 1.6
million contracts in December 2012 increased 17.4% from December
2011 and increased 0.3% from November 2012. In the fourth quarter
of 2012, total fixed income products ADV of 1.6 million contracts
was 13.3% below prior year levels. For the full-year 2012, total
fixed income products ADV of 1.8 million contracts was 22.0% below
prior year levels.
- Total equity products (including
Bclear) ADV of 1.8 million contracts in December 2012 decreased
10.6% compared to December 2011 and decreased 21.9% from November
2012. The 1.8 million contracts in equity products ADV consisted of
1.3 million contracts in individual equity products ADV and 0.5
million contracts in equity index products ADV. The 1.3 million
contracts in individual equity products ADV consisted of 0.9
million in futures contracts, which represented a 14.0% decrease
compared to December 2011 and 0.4 million in options contracts,
which represented a 17.9% decrease compared to December 2011. In
the fourth quarter of 2012, total equity products ADV of 1.9
million contracts were 7.6% below prior year levels. For the
full-year 2012, total equity products ADV of 1.9 million contracts
were 12.3% below prior year levels.
- Total commodities products ADV of
97,000 contracts in December 2012 increased 43.3% compared to
December 2011 and increased 12.5% compared to November 2012. In the
fourth quarter of 2012, total commodities product ADV of 96,500
contracts was 34.3% above prior year levels. For the full-year
2012, total commodities product ADV of 89,000 contracts was 10.6%
above prior year levels.
U.S. Derivatives
- NYSE Euronext U.S. equity options (NYSE
Arca and NYSE Amex Options) ADV of 3.9 million contracts in
December 2012 decreased 1.2% compared to December 2011 and
decreased 4.4% compared to November 2012. In the fourth quarter of
2012, U.S. equity options ADV of 4.0 million contracts was 6.7%
below prior year levels. For the full-year 2012, U.S. equity
options ADV of 3.9 million contracts was 11.6% below prior year
levels.
- Total U.S. consolidated equity options
ADV increased 0.4% to 14.3 million contracts in December 2012
compared to December 2011, but decreased 1.5% compared to November
2012. In the fourth quarter of 2012, U.S. consolidated equity
options ADV of 14.3 million contracts was 7.6% below prior year
levels. For the full-year 2012, U.S. consolidated equity options
ADV of 14.7 million contracts was 12.2% below prior year
levels.
- NYSE Euronext’s U.S. options exchanges
accounted for 27.2% of the total U.S. consolidated equity options
trading in December 2012, down from 27.7% in December 2011 and down
slightly from a record 28.1% in November 2012.
- NYSE Liffe U.S. ADV of approximately
72,600 contracts decreased from 89,600 contracts in December 2011,
but increased from 51,500 contracts in November 2012. In December
2012, the mini MSCI Index futures traded a record ADV of 41,570
contracts, an increase of 108% compared to December 2011, and open
interest across the entire MSCI complex hit an all time high on
December 19, 2012 of 267,932 contracts. In the fourth quarter of
2012, U.S. futures and futures options ADV of 55,200 contracts was
39.4% below prior year levels. For the full-year 2012, U.S. futures
and futures options ADV of 72,700 contracts was 10.4% below prior
year levels.
Cash Trading
European Cash
- NYSE Euronext European cash products
ADV of 1.1 million transactions in December 2012 decreased 20.2%
compared to December 2011 and decreased 8.7% compared to November
2012.
- NYSE Euronext market share in European
Cash products in December 2012 was 68.7%, up from 66.0% in December
2011 and up from 64.9% in November 2012.
- In the fourth quarter of 2012, European
cash products market share was 66.5% with ADV of 1.2 million
transactions which was 25.6% below prior year levels.
- For the full-year 2012, European cash
products market share was 66.2% with ADV of 1.4 million
transactions which was 15.5% below prior year levels.
U.S. Cash
- NYSE Euronext U.S. cash products
handled ADV in December 2012 decreased 14.7% to 1.5 billion shares
compared to December 2011 and decreased 3.4% from November
2012.
- In the fourth quarter of 2012, U.S.
cash products handled ADV was 1.6 billion shares, down 27.3% from
prior year levels.
- For the full-year 2012, U.S. cash
products handled ADV was 1.7 billion shares, down 26.2% from prior
year levels.
- NYSE Euronext’s Tape A matched market
share in December 2012 was 31.9%, down from 33.4% in December 2011,
but up from 31.7% in November 2012.
Exchange Traded Funds
- NYSE Euronext U.S. matched
exchange-traded funds ADV (included in volumes for Tape B and Tape
C) of 193 million shares in December 2012 decreased 22.1% compared
to December 2011 and decreased 7.5% compared to November 2012.
- In the fourth quarter of 2012, NYSE
Euronext U.S. matched exchange-traded funds ADV of 197 million
shares was 38.9% below prior year levels.
- For the full-year 2012, NYSE Euronext
U.S. matched exchange-traded funds ADV of 211 million shares was
34.9% below prior year levels.
Other Metrics
- On October 5, 2012, NYSE Euronext
closed on the public offering of $850 million 2.00% notes due in
October 2017. The proceeds from this offering were used to fund the
purchase of $336 million of our outstanding $750 million 4.80%
notes due in June 2013 and €80 million of our €1 billion 5.375%
notes due in June 2015 and for other general corporate purposes,
including the reduction in outstanding commercial paper. As a
result of the refinancing, interest expense is expected to decline
by approximately $1 million in the fourth quarter of 2012,
excluding a $24 million one-time charge for the refinancing which
will be excluded from fourth quarter 2012 non-GAAP financial
results. The refinancing is expected to save an annualized $15
million and $24 million in interest expense in 2013 and 2014,
respectively.
- The average EUR/USD exchange rate for
the fourth quarter of 2012 of $1.30 represented an increase of 3.7%
from the third quarter of 2012 and a decrease of 3.8% compared to
the fourth quarter of 2011. The average GBP/USD exchange rate for
the fourth quarter of 2012 of $1.61 represented an increase of 1.6%
from the third quarter of 2012 and an increase of 2.1% compared to
the fourth quarter of 2011.
- During the fourth quarter of 2012, a
total of 1.1 million shares were repurchased at an average price of
$24.67. As a result of these repurchases, the weighted average
diluted shares outstanding in the fourth quarter of 2012 was 245
million shares.
Please click here for the Monthly Transaction Activity Data
Table.
About NYSE Euronext
NYSE Euronext (NYX) is a leading global operator of financial
markets and provider of innovative trading technologies. The
company's exchanges in Europe and the United States trade equities,
futures, options, fixed-income and exchange-traded products. With
approximately 8,000 listed issues (excluding European Structured
Products), NYSE Euronext's equities markets - the New York Stock
Exchange, NYSE Euronext, NYSE MKT, NYSE Alternext and NYSE Arca -
represent one-third of the world’s equities trading, the most
liquidity of any global exchange group. NYSE Euronext also operates
NYSE Liffe, one of the leading European derivatives businesses and
the world's second-largest derivatives business by value of
trading. The company offers comprehensive commercial technology,
connectivity and market data products and services through NYSE
Technologies. NYSE Euronext is in the S&P 500 index. For more
information, please visit: http://www.nyx.com.
Forward-Looking Statements
This press release may contain “forward-looking statements” made
pursuant to the safe harbor provisions of the Private Securities
Litigation Reform Act of 1995. In some cases, you can identify
forward-looking statements by words such as “may,” “hope,” “will,”
“should,” “expect,” “plan,” “anticipate,” “intend,” “believe,”
“estimate,” “predict,” “potential,” “continue,” “could,” “future”
or the negative of those terms or other words of similar meaning.
You should carefully read forward-looking statements, including
statements that contain these words, because they discuss our
future expectations or state other “forward-looking” information.
Forward-looking statements involve a number of risks and
uncertainties. ICE and NYSE Euronext caution readers that any
forward-looking statement is not a guarantee of future performance
and that actual results could differ materially from those
contained in the forward-looking statement. Such forward-looking
statements include, but are not limited to, statements about the
benefits of the proposed merger involving ICE and NYSE Euronext,
including future financial results, ICE’s and NYSE Euronext’s
plans, objectives, expectations and intentions, the expected timing
of completion of the transaction and other statements that are not
historical facts. Important factors that could cause actual results
to differ materially from those indicated by such forward-looking
statements are set forth in ICE’s and NYSE Euronext’s filings with
the U.S. Securities and Exchange Commission (the “SEC”). These
risks and uncertainties include, without limitation, the following:
the inability to close the merger in a timely manner; the inability
to complete the merger due to the failure of NYSE Euronext
stockholders to adopt the merger agreement or the failure of ICE
stockholders to approve the issuance of ICE common stock in
connection with the merger; the failure to satisfy other conditions
to completion of the merger, including receipt of required
regulatory and other approvals; the failure of the proposed
transaction to close for any other reason; the possibility that any
of the anticipated benefits of the proposed transaction will not be
realized; the risk that integration of NYSE Euronext’s operations
with those of ICE will be materially delayed or will be more costly
or difficult than expected; the challenges of integrating and
retaining key employees; the effect of the announcement of the
transaction on ICE’s, NYSE Euronext’s or the combined company’s
respective business relationships, operating results and business
generally; the possibility that the anticipated synergies and cost
savings of the merger will not be realized, or will not be realized
within the expected time period; the possibility that the merger
may be more expensive to complete than anticipated, including as a
result of unexpected factors or events; diversion of management’s
attention from ongoing business operations and opportunities;
general competitive, economic, political and market conditions and
fluctuations; actions taken or conditions imposed by the United
States and foreign governments and regulatory authorities; and
adverse outcomes of pending or threatened litigation or government
investigations. In addition, you should carefully consider the
risks and uncertainties and other factors that may affect future
results of the combined company described in the section entitled
“Risk Factors” in the joint proxy statement/prospectus to be
delivered to ICE’s and NYSE Euronext’s respective shareholders, and
in ICE’s and NYSE Euronext’s respective filings with the SEC that
are available on the SEC’s web site located at www.sec.gov,
including the sections entitled “Risk Factors” in ICE’s Form 10−K
for the fiscal year ended December 31, 2011, as filed with the SEC
on February 8, 2012, and ICE's Quarterly Reports on Form 10-Q for
the quarters ended June 30, 2012, as filed with the SEC on August
1, 2012 and September 30, 2012, as filed with the SEC on November
5, 2012, and “Risk Factors” in NYSE Euronext’s Form 10−K for the
fiscal year ended December 31, 2011, as filed with the SEC on
February 29, 2012. You should not place undue reliance on
forward-looking statements, which speak only as of the date of this
press release. Except for any obligations to disclose material
information under the Federal securities laws, NYSE Euronext
undertakes no obligation to publicly update any forward-looking
statements to reflect events or circumstances after the date of
this press release.
Important Information About the Proposed Transaction and
Where to Find It:
In connection with the proposed transaction, ICE intends to file
with the SEC a registration statement on Form S−4, which will
include a joint proxy statement/prospectus with respect to the
proposed acquisition of NYSE Euronext. The final joint proxy
statement/prospectus will be delivered to the stockholders of ICE
and NYSE Euronext. Investors and security holders of both ICE and
NYSE Euronext are urged to read the joint proxy
statement/prospectus regarding the proposed transaction carefully
and in its entirety, including any documents previously filed with
the SEC and incorporated by reference into the joint proxy
statement/prospectus, when it becomes available because it will
contain important information regarding ICE, NYSE Euronext and the
proposed merger. Investors will be able to obtain a free copy of
the joint proxy statement/prospectus, as well as other filings
containing information about ICE and NYSE Euronext, without charge,
at the SEC’s website at http://www.sec.gov/. Investors may also
obtain these documents, without charge, from ICE’s website at
http://www.theice.com.
Participants in the Merger Solicitation:
ICE, NYSE Euronext and their respective directors, executive
officers and other members of management and employees may be
deemed to be participants in the solicitation of proxies in respect
of the transactions contemplated by the merger agreement.
You can find information about ICE and ICE’s directors and
executive officers in ICE’s Annual Report on Form 10-K for the year
ended December 31, 2011, as filed with the SEC on February 8, 2012,
and ICE’s proxy statement for its 2012 annual meeting of
stockholders, as filed with the SEC on March 30, 2012.
You can find information about NYSE Euronext and NYSE Euronext’s
directors and executive officers in NYSE Euronext’s Annual Report
on Form 10-K for the year ended December 31, 2011, as filed with
the SEC on February 29, 2012, and NYSE Euronext’s proxy statement
for its 2012 annual meeting of stockholders, filed with the SEC on
March 26, 2012.
Additional information about the interests of potential
participants will be included in the joint proxy
statement/prospectuses, if and when it becomes available, and the
other relevant documents filed by ICE and NYSE Euronext with the
SEC.
This announcement does not constitute and offer or any
solicitation of any offer, to buy or subscribe for any
securities.
1 All NYSE Euronext derivatives transactions count buy and sell
orders together as a single transaction. NYSE Euronext European
equities transactions count each buy and sell order as separate
transactions, NYSE Euronext U.S. equities transactions count buy
and sell orders together as a single transaction.
NYSE
Euronext
Monthly Volume
Summary
Average Daily Volume
Total Volume Average Daily
Volume Total Volume
(Unaudited; contracts in thousands)
Dec-12
Dec-11 %
Chg Dec-12
Dec-11 % Chg
YTD 2012
% Chg vs.
YTD 2011
YTD 2012
% Chg vs.
YTD 2011
Number of Trading Days - European Cash 19 21 19 21 256 256
Number of Trading Days - European Derivatives 19 21 19 21 257 257
Number of Trading Days - U.S. Markets 20 21 20 21 250 250
European Derivatives Products 3,491 3,440
1.5% 66,326 72,245 -8.2% 3,719
-16.8% 955,802 -16.8% of which Bclear 1,103
1,240 -11.1% 20,949 26,046 -19.6% 1,103 -3.3% 283,554 -3.3%
Total Fixed Income Products 1,587 1,352
17.4% 30,146 28,390 6.2% 1,754
-22.0% 450,896 -22.0% Short Term
Interest Rate Products 1,468 1,268 15.8% 27,897 26,625 4.8% 1,602
-24.1% 411,806 -24.1% Medium and Long Term Interest Rate Products 1
118 84 40.8% 2,249 1,766 27.4% 152 9.5% 39,089 9.5%
Total
Equity Products 2 1,807 2,021
-10.6% 34,335 42,432 -19.1%
1,875 -12.3% 481,969 -12.3%
Individual Equity Products 1,296 1,529 -15.2% 24,626 32,109 -23.3%
1,398 -10.4% 359,382 -10.4% Futures 907 1,056 -14.0% 17,241 22,168
-22.2% 959 -1.6% 246,542 -1.6% Options 389 473 -17.9% 7,385 9,941
-25.7% 439 -25.1% 112,841 -25.1% Equity Index Products 511 492 3.9%
9,709 10,323 -6.0% 477 -17.5% 122,587 -17.5% of which Bclear
1,103 1,240 -11.1% 20,949 26,046 -19.6% 1,103 -3.3% 283,554 -3.3%
Individual Equity Products 983 1,142 -14.0% 18,671 23,986 -22.2%
1,027 -3.1% 263,840 -3.1% Futures 907 1,055 -14.0% 17,241 22,165
-22.2% 938 -2.2% 240,967 -2.2% Options 75 87 -13.2% 1,430 1,820
-21.4% 89 -11.9% 22,873 -11.9% Equity Index Products 120 98 22.2%
2,278 2,060 10.6% 77 -5.5% 19,714 -5.5%
Commodity
Products 97 68 43.3% 1,844
1,422 29.7% 89 10.6% 22,937
10.6% U.S. Derivatives Products
Equity Options 3 NYSE Euronext Options
Contracts 3,888 3,936 -1.2% 77,767 82,656 -5.9% 3,893 -11.6%
973,140 -12.3% Total Consolidated Options Contracts 14,275 14,224
0.4% 285,492 298,702 -4.4% 14,727 -12.2% 3,681,821 -12.8%
NYSE Group Share of Total 27.2% 27.7% 27.2% 27.7% 26.4% 0.1% 26.4%
0.1%
NYSE Liffe U.S. Futures and Futures
Options Volume* 72.6 89.6 -19.0% 1,452 1,882 -22.8% 72.7 -10.4%
18,769.2 -10.4%
European Cash Products (trades in
thousands) 1,068 1,338 -20.2%
20,297 28,095 -27.8% 1,445
-15.5% 370,013 -15.9% Equities 1,026
1,287 -20.2% 19,503 27,023 -27.8% 1,396 -15.1% 357,365 -15.4%
Exchange-Traded Funds 12 15 -25.0% 221 325 -32.1% 13 -35.0% 3,412
-35.2% Structured Products 24 31 -20.9% 459 642 -28.4% 31 -25.7%
7,885 -26.0% Bonds 6 5 20.5% 114 104 9.0% 5 5.8% 1,350 5.3%
U.S. Cash Products (shares in millions) 5
1,531 1,794 -14.7% 30,623 37,682
-18.7% 1,685 -26.2% 421,338
-26.8% NYSE Listed (Tape A) Issues 4
Handled Volume 5 1,110 1,277 -13.1% 22,196 26,821 -17.2%
1,207 -24.9% 301,769 -25.5% Matched Volume 6 1,068 1,212 -11.8%
21,363 25,445 -16.0% 1,147 -24.7% 286,785 -25.3% Total NYSE Listed
Consolidated Volume 3,353 3,623 -7.4% 67,069 76,086 -11.9% 3,659
-16.3% 914,654 -16.9%
Share of Total Consolidated
Volume Handled Volume 5 33.1% 35.3% -2.2% 33.1% 35.3% -2.2%
33.0% -3.8% 33.0% -3.8% Matched Volume 6 31.9% 33.4% -1.5% 31.9%
33.4% -1.5% 31.4% -3.5% 31.4% -3.5%
NYSE Arca, MKT and
Regional (Tape B) Listed Issues Handled Volume 5 225 295
-23.7% 4,501 6,192 -27.3% 248 -35.0% 61,957 -35.5% Matched Volume 6
209 263 -20.6% 4,171 5,517 -24.4% 225 -34.6% 56,127 -35.1% Total
NYSE Arca & MKT Listed Consolidated Volume 970 1,170 -17.1%
19,403 24,580 -21.1% 1,055 -28.4% 263,832 -29.0%
Share of
Total Consolidated Volume Handled Volume 5 23.2% 25.2% -2.0%
23.2% 25.2% -2.0% 23.5% -2.4% 23.5% -2.4% Matched Volume 6 21.5%
22.4% -0.9% 21.5% 22.4% -0.9% 21.3% -2.0% 21.3% -2.0%
Nasdaq Listed (Tape C) Issues Handled Volume 5 196
222 -11.7% 3,926 4,669 -15.9% 230 -21.8% 57,612 -22.4% Matched
Volume 6 175 189 -7.5% 3,506 3,979 -11.9% 199 -21.6% 49,756 -22.2%
Total Nasdaq Listed Consolidated Volume 1,689 1,615 4.6% 33,776
33,911 -0.4% 1,749 -13.5% 437,168 -14.2%
Share of Total
Consolidated Volume Handled Volume 5 11.6% 13.8% -2.2% 11.6%
13.8% -2.2% 13.2% -1.4% 13.2% -1.4% Matched Volume 6 10.4% 11.7%
-1.3% 10.4% 11.7% -1.3% 11.4% -1.2% 11.4% -1.2%
Exchange-Traded Funds 5,7 Handled Volume 5 208
279 -25.3% 4,166 5,854 -28.8% 233 -35.4% 58,195 -35.9% Matched
Volume 6 193 248 -22.1% 3,858 5,202 -25.8% 211 -34.9% 52,682 -35.5%
Total ETF Consolidated Volume 929 1,139 -18.5% 18,575 23,917 -22.3%
1,020 -28.2% 255,004 -28.7%
Share of Total Consolidated
Volume Handled Volume 5 22.4% 24.5% -2.1% 22.4% 24.5% -2.1%
22.8% -2.5% 22.8% -2.5% Matched Volume 6 20.8% 21.7% -0.9% 20.8%
21.7% -0.9% 20.7% -2.1% 20.7% -2.1% 1 Data includes
currency products.
2
Includes all trading activities for Bclear, NYSE Liffe's clearing
service for wholesale derivatives. 3 Includes trading in U.S.
equity options contracts, not equity-index options. 4 Includes all
volume executed in NYSE Group crossing sessions. 5 Represents the
total number of shares of equity securities and ETFs internally
matched on the NYSE Group's exchanges or routed to and executed at
an external market center. NYSE Arca routing includes odd-lots. 6
Represents the total number of shares of equity securities and ETFs
executed on the NYSE Group's exchanges. 7 Data included in
previously identified categories. * ADVs calculated with the
appropriate number of NYSE Liffe U.S. trading days. Source: NYSE
Euronext, Options Clearing Corporation and Consolidated Tape as
reported for equity securities. All trading activity is
single-counted, except European cash trading which is double
counted to include both buys and sells.
nyx.com
Please follow us at:Exchanges BlogFacebookLinkedInTwitter
Grafico Azioni NYSE Group (NYSE:NYX)
Storico
Da Giu 2024 a Lug 2024
Grafico Azioni NYSE Group (NYSE:NYX)
Storico
Da Lug 2023 a Lug 2024